Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

CAMPTOSAR®How Supplied/Storage and Handling (irinotecan HCl)


CAMPTOSAR (irinotecan hydrochloride) Injection is available as a sterile, pale yellow, clear, aqueous solution in a vial packaged within a carton in the following packaging configurations:

  • Single-dose amber colored polypropylene CYTOSAFE® vial presentations:
    • 40 mg/2 mL (20 mg/mL) NDC 0009-7529-04
    • 100 mg/5 mL (20 mg/mL) NDC 0009-7529-03
    • 300 mg/15 mL (20 mg/mL) NDC 0009-7529-05

Store at controlled room temperature 15°C to 30°C (59° to 86°F). Protect from light. Keep the vial in the carton until the time of use.

Inspect the vial for damage and visible signs of leaks before removing from the carton. If damaged, incinerate the unopened package.

CAMPTOSAR is a hazardous drug. Follow special handling and disposal procedures.1

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event